0 Comentários
0 Compartilhamentos
57KB Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Solid Tumors Market Insights: Growth, Share, Value, Size, and Trends"Regional Overview of Executive Summary Solid Tumors Market by Size and Share Global solid tumors market size was valued at USD 362.21 billion in 2024 and is projected to reach USD 1557.42 billion by 2032, with a CAGR of 20.00% during the forecast period of 2025 to 2032. A consistent market research report like Solid Tumors Market report extends reach to the success in the...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Comentários 0 Compartilhamentos 803 Visualizações 0 Anterior
-
3D and 4D Ultrasound Devices Market Insights: Growth, Share, Value, Size, and Trends"Executive Summary 3D and 4D Ultrasound Devices Market: Growth Trends and Share Breakdown Data Bridge Market Research analyses that the 3D and 4D Ultrasound Devices market which was USD 7.28 billion in 2022, would rocket up to USD 35.97 billion by 2030, and is expected to undergo a CAGR of 3.98% during the forecast period of 2023 to 2030. The 3D and 4D Ultrasound Devices Market report...0 Comentários 0 Compartilhamentos 261KB Visualizações 0 Anterior
-
Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior